Long-Term Therapy with Recombinant Interferon-Gamma (rIFN-γ) for Atopic Dermatitis
- 1 March 1998
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 80 (3) , 263-268
- https://doi.org/10.1016/s1081-1206(10)62968-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Atopic dermatitis: The skin as a window into the pathogenesis of chronic allergic diseasesJournal of Allergy and Clinical Immunology, 1995
- Antigen presenting cell-independent cytokine and spontaneous in vitro IgE production in patients with atopic dermatitis: Increased interferon-γ production and lack of effects of in vivo low-dose interferon-γ treatmentJournal of Allergy and Clinical Immunology, 1995
- My skin is only the top layer of the problemArchives of Dermatology, 1995
- Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis.Journal of Clinical Investigation, 1994
- Interferon therapy for atopic dermatitis reduces basophil histamine release, but does not reduce serum IgE or eosinophilic proteinsAllergy, 1994
- Systemic interferon gamma treatment in severe atopic dermatitisJournal of the American Academy of Dermatology, 1993
- Recombinant interferon gamma therapy for atopic dermatitisJournal of the American Academy of Dermatology, 1993
- Regulation of IgE synthesis in humans: A tale of two signalsJournal of Allergy and Clinical Immunology, 1991
- Aeroallergen contact can exacerbate atopic dermatitis: Patch tests as a diagnostic toolJournal of the American Academy of Dermatology, 1989
- Food hypersensitivity and atopic dermatitis: Evaluation of 113 patientsThe Journal of Pediatrics, 1985